| scholarly article | Q13442814 |
| P50 | author | David P. Lane | Q909289 |
| P2093 | author name string | Gloria Fuentes | |
| Chandra S Verma | |||
| Srinivasaraghavan Kannan | |||
| Yao Zong Ng | |||
| P2860 | cites work | An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor | Q24293598 |
| EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization | Q24296900 | ||
| Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains | Q24307661 | ||
| Interaction of antibodies with ErbB receptor extracellular regions | Q37320814 | ||
| Characterization of Glycosylation Sites of the Epidermal Growth Factor Receptor | Q37396323 | ||
| Randomized phase II study of dacomitinib (PF-00299804), an irreversible pan-human epidermal growth factor receptor inhibitor, versus erlotinib in patients with advanced non-small-cell lung cancer. | Q37659109 | ||
| Emerging concepts in the regulation of the EGF receptor and other receptor tyrosine kinases. | Q38253000 | ||
| Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity | Q39908130 | ||
| Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor | Q40568272 | ||
| HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy | Q40730426 | ||
| Cryptic T-cell epitopes and their role in the pathogenesis of autoimmune diseases | Q41664274 | ||
| Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties | Q41966195 | ||
| HIVgp120 activates autoreactive CD4-specific T cell responses by unveiling of hidden CD4 peptides during processing | Q42942993 | ||
| Structural basis for inhibition of the epidermal growth factor receptor by cetuximab | Q45345151 | ||
| Bio3d: an R package for the comparative analysis of protein structures. | Q46122078 | ||
| Electrostatics-defying interaction between arginine termini as a thermodynamic driving force in protein-protein interaction | Q46489549 | ||
| Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene | Q48647863 | ||
| Structural model of the mAb 806-EGFR complex using computational docking followed by computational and experimental mutagenesis | Q51249291 | ||
| Generalized born model with a simple smoothing function | Q52009475 | ||
| CHARMM: A program for macromolecular energy, minimization, and dynamics calculations | Q53340989 | ||
| How can cryptic epitopes trigger autoimmunity? | Q24678950 | ||
| Comparison of simple potential functions for simulating liquid water | Q26778447 | ||
| Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab | Q27640593 | ||
| Antibodies specifically targeting a locally misfolded region of tumor associated EGFR | Q27654155 | ||
| Structures of adnectin/protein complexes reveal an expanded binding footprint | Q27677197 | ||
| Two potential therapeutic antibodies bind to a peptide segment of membrane-bound IgE in different conformations | Q27688964 | ||
| EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy | Q27824812 | ||
| All-atom empirical potential for molecular modeling and dynamics studies of proteins | Q27860468 | ||
| VMD: visual molecular dynamics | Q27860554 | ||
| Scalable molecular dynamics with NAMD | Q27860718 | ||
| HADDOCK: a protein-protein docking approach based on biochemical or biophysical information | Q27860814 | ||
| Ligand-induced, receptor-mediated dimerization and activation of EGF receptor | Q28646134 | ||
| Erlotinib in previously treated non-small-cell lung cancer | Q29547546 | ||
| Comparative protein structure modeling using Modeller | Q29615142 | ||
| HADDOCK versus HADDOCK: new features and performance of HADDOCK2.0 on the CAPRI targets | Q29615981 | ||
| Anatomy of hot spots in protein interfaces | Q29616238 | ||
| EGF-ERBB signalling: towards the systems level | Q29619032 | ||
| Steered molecular dynamics investigations of protein function. | Q30328260 | ||
| Long-timescale molecular dynamics simulations of protein structure and function. | Q30376113 | ||
| Binding pathway of retinal to bacterio-opsin: a prediction by molecular dynamics simulations | Q33907934 | ||
| Molecular dynamics study of unbinding of the avidin-biotin complex | Q33915230 | ||
| Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex | Q34314489 | ||
| A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor | Q34470390 | ||
| Functional dissection of the epidermal growth factor receptor epitopes targeted by panitumumab and cetuximab. | Q34504860 | ||
| Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silicobased mechanism | Q35558065 | ||
| Regulation of the catalytic activity of the EGF receptor. | Q35597077 | ||
| Is allostery an intrinsic property of all dynamic proteins? | Q35894622 | ||
| Epidermal growth factor receptor targeting in cancer | Q36557269 | ||
| The epidermal growth factor receptor pathway: a model for targeted therapy | Q36603677 | ||
| Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer. | Q36710542 | ||
| Architecture and membrane interactions of the EGF receptor | Q36923502 | ||
| Overcoming the inadequacies or limitations of experimental structures as drug targets by using computational modeling tools and molecular dynamics simulations | Q36931811 | ||
| Principles of protein-protein interactions: what are the preferred ways for proteins to interact? | Q37114752 | ||
| Anti-c-Met antibodies recognising a temperature sensitive epitope, inhibit cell growth | Q37138521 | ||
| Structure-based view of epidermal growth factor receptor regulation | Q37197992 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 153-168 | |
| P577 | publication date | 2014-11-18 | |
| P1433 | published in | Proteins | Q7251514 |
| P1476 | title | mAb806 binding to epidermal growth factor receptor: a computational study | |
| P478 | volume | 83 |
Search more.